Monkeypox Virus Seroprevalence among Adults Assessed at Roadside Wellness Centers along Major Transportation Corridor, Kenya, 2025

Background: Since July 2024, Kenya has been experiencing its first monkeypox outbreak. Although over 1,000 cases have been confirmed, gaps in case‑based surveillance could lead to under-ascertainment. To better quantify unrecognized transmission, we conducted a monkeypox serosurvey at clinics along a high‑mobility transportation corridor in Kenya. Methods: We performed a cross-sectional serosurvey at eight clinics between 29 September to 28 October 2025. Adults ≥18 years completed a standardized questionnaire and provided blood samples tested using a multiplex‑bead serologic assay capable of distinguishing likely infection from orthopoxvirus vaccination. Seroprevalence was defined as the proportion of participants who tested seropositive out of all participants with valid test results. Associations with likely infection were assessed using modified Poisson regression with cluster‑robust standard errors. To assess under‑ascertainment, we compared the number of participants with serologic evidence of likely monkeypox infection to the number self‑reporting a prior laboratory‑confirmed monkeypox case. Findings: Of 2,896 participants with valid results, 332 (11.5%) were seropositive, including 82 (2.8%) classified as likely infection. Sex workers (6.4%) and truck drivers (4.1%) had the highest likely infection prevalence. Four participants reported prior confirmed monkeypox cases; all were seropositive. The ratio of persons with likely infections to previously confirmed cases was 21:1. Interpretation: These findings indicate under‑ascertainment of monkeypox infections in high‑risk communities in Kenya. Despite some evidence of undetected transmission, most participants lacked serological evidence of prior orthopoxvirus exposure indicating a potentially large susceptible population. These findings suggest diagnostic access, vaccination among high-risk groups, and ongoing serosurveillance may be important considerations for strengthening outbreak response.

Authors

Institutions

Publication Details

Journal
Emerging infectious diseases
Published
2026-11-04
DOI
https://doi.org/10.3201/eid3212.260957
Primary Topic
Poxvirus research and outbreaks
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Monkeypox Virus Seroprevalence among Adults Assessed at Roadside Wellness Centers along Major Transportation Corridor, Kenya, 2025

Daniel Langat, Gilbert K. Kikwai, Jonas Zajac Hines, Henry Mwazighe et al.
4 links
Emerging infectious diseases
Poxvirus research and outbreaks
article

Monkeypox Virus Seroprevalence among Adults Assessed at Roadside Wellness Centers along Major Transportation Corridor, Kenya, 2025

Daniel Langat, Gilbert K. Kikwai, Jonas Zajac Hines, Henry Mwazighe, Damaris Lagat, Christina Mwachari, Cyrus Kagecha, Eva Mwai, Caroline Ochieng, Naomi Lucchi, Emily Koech
article en

Abstract

Background: Since July 2024, Kenya has been experiencing its first monkeypox outbreak. Although over 1,000 cases have been confirmed, gaps in case‑based surveillance could lead to under-ascertainment. To better quantify unrecognized transmission, we conducted a monkeypox serosurvey at clinics along a high‑mobility transportation corridor in Kenya. Methods: We performed a cross-sectional serosurvey at eight clinics between 29 September to 28 October 2025. Adults ≥18 years completed a standardized questionnaire and provided blood samples tested using a multiplex‑bead serologic assay capable of distinguishing likely infection from orthopoxvirus vaccination. Seroprevalence was defined as the proportion of participants who tested seropositive out of all participants with valid test results. Associations with likely infection were assessed using modified Poisson regression with cluster‑robust standard errors. To assess under‑ascertainment, we compared the number of participants with serologic evidence of likely monkeypox infection to the number self‑reporting a prior laboratory‑confirmed monkeypox case. Findings: Of 2,896 participants with valid results, 332 (11.5%) were seropositive, including 82 (2.8%) classified as likely infection. Sex workers (6.4%) and truck drivers (4.1%) had the highest likely infection prevalence. Four participants reported prior confirmed monkeypox cases; all were seropositive. The ratio of persons with likely infections to previously confirmed cases was 21:1. Interpretation: These findings indicate under‑ascertainment of monkeypox infections in high‑risk communities in Kenya. Despite some evidence of undetected transmission, most participants lacked serological evidence of prior orthopoxvirus exposure indicating a potentially large susceptible population. These findings suggest diagnostic access, vaccination among high-risk groups, and ongoing serosurveillance may be important considerations for strengthening outbreak response.

Emerging infectious diseasesVol. 32(12)
Centers for Disease Control and Prevention (US), Government of the United States of America (US), Kenya Medical Research Institute (KE), Centers for Disease Control and Prevention (UG), Centers for Disease Control and Prevention (KE)
Good health and well-being
Openalex Percentile: Top 70%
Poxvirus research and outbreaks
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon